Jastreboff M M, Zielińska Z M
Acta Biochim Pol. 1983;30(2):185-91.
A subline of Ehrlich ascites carcinoma (EAC) cells resistant to 5-fluoro-2'-deoxy-uridine (FdUrd) was developed by continuous exposure to progressively increasing concentrations of the drug (35-75 mg/kg per day) during 15 passages through mice. Since then, the EAC cells have been retransplanted more than 80 times through drug-untreated mice and continue to be resistant. After adaptation to growth in suspension culture the drug-adapted cells were 1000 times more resistant to FdUrd in comparison with parental ones, and remained near-tetraploid with doubling time longer than in parental line. The activity of thymidine kinase was deeply depressed (100-fold) whereas that of thymidylate synthetase several-fold increased in the resistant EAC cells, both grown in vivo and in vitro.
通过在小鼠体内连续传代15次,使其不断接触浓度逐渐增加的药物(每天35 - 75毫克/千克),培育出了一种对5-氟-2'-脱氧尿苷(FdUrd)具有抗性的艾氏腹水癌细胞(EAC)亚系。从那时起,EAC细胞已通过未用药的小鼠进行了80多次再移植,并且仍然具有抗性。在适应悬浮培养生长后,与亲代细胞相比,适应药物的细胞对FdUrd的抗性高1000倍,并且仍接近四倍体,其倍增时间比亲代细胞系更长。无论是在体内还是体外生长的抗性EAC细胞中,胸苷激酶的活性都显著降低(100倍),而胸苷酸合成酶的活性则增加了几倍。